FLUIDDA'S Technology Assists in Optimizing Treatment for COPD Patients
Kontich, Belgium (ots/PRNewswire) - FLUIDDA's breakthrough imaging technology was used to assess the mode of action of Roflumilast, a novel drug to treat patients suffering from chronic obstructive pulmonary disease (COPD). FLUIDDA's study clearly demonstrated that the drug was superior to placebo and very effective in a subset of patients. Furthermore, the study ...
mehr